This hypothesis was supported by a synthetic lethal screen using siRNA in which simultaneous targeting of RAF and MEK was shown to lead to enhanced inhibition in K‐RAS‐mutated cancer cells (Lamba et al., 2014). The gene discussed is KRAS; the disease is cancer.